Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HUMANA INCHUM · Entity 1429 | Director | January 02, 2026 | January 05, 2026 |
| Hewlett Packard Enterprise CoHPE · Entity 2984 | Director | May 01, 2026 | May 05, 2026 |
| PFIZER INCPFE · Entity 2863 | Executive Vice President | February 26, 2022 | March 01, 2022 |
| Viatris IncVTRS · Entity 3277 | Director | March 06, 2026 | March 10, 2026 |
| Zoetis Inc.ZTS · Entity 679 | Director | August 07, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HUMANA INC
Report date January 02, 2026 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 26,826 |
Reported balance
After 2026-01-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-02 · Grant · Acquired 766 · Balance 26,826 F1: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,467 |
Reported balance
Holding disclosure · report date 2026-01-02 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 2,467 F2: Director's cash fee elected to be converted into stock units, deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis (over a five-year period), exempt pursuant to Rule 16(b)-3(d)(1). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 318 |
Reported balance
Holding disclosure · report date 2026-01-02 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 318 F3: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). |
| Humana CommonSEC Table I · non-derivative | IndirectSee Footnote | 20,634 |
Reported balance
Holding disclosure · report date 2026-01-02 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 20,634 F4: Transferred 20,634 shares into new 2024 Grantor Retained Annuity Trust effective 4/29/24, where reporting person is the sole Trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.
F2: Director's cash fee elected to be converted into stock units, deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis (over a five-year period), exempt pursuant to Rule 16(b)-3(d)(1).
F3: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
F4: Transferred 20,634 shares into new 2024 Grantor Retained Annuity Trust effective 4/29/24, where reporting person is the sole Trustee.
Hewlett Packard Enterprise Co
Report date May 01, 2026 · Filed May 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 8,750 |
Reported balance
After 2026-05-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-01 · Grant · Acquired 8,750 · Balance 8,750 F3: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F4: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors. |
| Common StockSEC Table I · non-derivative | Direct | 3,444 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 3,444 |
| Common StockSEC Table I · non-derivative | IndirectBy Merrill Lynch | 47,721.7622 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 47,721.7622 F1: The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors. F2: The number of shares in column 5 includes 144.4031 vested restricted stock unit ("RSU") dividend equivalent rights at $27.93 per RSU credited to the reporting person's account on 04/23/26. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.
F2: The number of shares in column 5 includes 144.4031 vested restricted stock unit ("RSU") dividend equivalent rights at $27.93 per RSU credited to the reporting person's account on 04/23/26.
F3: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
F4: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.
PFIZER INC
Report date February 26, 2022 · Filed March 01, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 555,941 |
Ending reported balance
After 2022-02-26 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-02-26 · Exercise / conversion · Acquired 127,160 · Balance 649,918 F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Row 2 · 2022-02-26 · Tax withholding · Disposed 34,607 · Balance 615,311 F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3: Price is the closing price of Pfizer common stock on February 25, 2022. Row 3 · 2022-02-26 · Tax withholding · Disposed 59,370 · Balance 555,941 F4: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $25.60 · Expires 2022-02-26 | Direct | 0 |
Reported balance
After 2022-02-26 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-02-26 · Exercise / conversion · Disposed 127,160 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3: Price is the closing price of Pfizer common stock on February 25, 2022.
F4: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F5: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
Viatris Inc
Report date March 06, 2026 · Filed March 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,031 |
Ending reported balance
After 2026-03-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-06 · Exercise / conversion · Acquired 25,112 · Balance 25,112 Row 2 · 2026-03-06 · Exercise / conversion · Acquired 919 · Balance 26,031 F1: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-03-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-03-06 · Exercise / conversion · Disposed 25,112 · Balance 0 F2: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 15,890 |
Reported balance
After 2026-03-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-06 · Grant · Acquired 15,890 · Balance 15,890 F4: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027. |
| Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-03-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-03-06 · Exercise / conversion · Disposed 918.455 · Balance 0 F3: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on May 12, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. |
Filing footnotes · ownership attribution and instrument terms
F1: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
F2: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026.
F3: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on May 12, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.
F4: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027.
Zoetis Inc.
Report date August 07, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,808 |
Reported balance
After 2026-08-07 transaction · row 1
1 source rowRow 1 · 2026-08-07 · Gift · Disposed 6,650 · Balance 14,808 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 6,650 |
Reported balance
Holding disclosure · report date 2026-08-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 6,650 F1: Reflects a transfer by the Reporting Person of 6,650 shares to the Frank A. D'Amelio 2-Year 2026 GRAT No. 3. F2: Shares held in the Frank A. D'Amelio 2-Year 2026 GRAT No. 3, to which the reporting person is a grantor, trustee and beneficiary. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a transfer by the Reporting Person of 6,650 shares to the Frank A. D'Amelio 2-Year 2026 GRAT No. 3.
F2: Shares held in the Frank A. D'Amelio 2-Year 2026 GRAT No. 3, to which the reporting person is a grantor, trustee and beneficiary.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Catalent, Inc.
Report date December 18, 2024 · Filed December 18, 2024
Section 16 reporting ended · disclosed 2024-12-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-12-18 transaction · row 1
1 source rowRow 1 · 2024-12-18 · Disposition to issuer · Disposed 12,635 · Balance 0 F1: On December 18, 2024, Creek Parent, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), dated as of February 5, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F2: Includes restricted stock units ("RSUs"). F3: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $63.50 in cash, without interest (the "Merger Consideration"). F4: At the Effective Time, each RSU, whether or not vested, outstanding immediately prior to the Effective Time vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer common stock subject to the RSU multiplied by (ii) the Merger Consideration, except for certain RSUs granted following the date of the Merger Agreement which were converted at the Effective Time into restricted cash awards equal to the product of (a) the Merger Consideration multiplied by (b) the number of shares of Issuer common stock subject to such award and otherwise remain subject to their terms, including vesting and acceleration terms. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 18, 2024, Creek Parent, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), dated as of February 5, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger").
F2: Includes restricted stock units ("RSUs").
F3: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $63.50 in cash, without interest (the "Merger Consideration").
F4: At the Effective Time, each RSU, whether or not vested, outstanding immediately prior to the Effective Time vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer common stock subject to the RSU multiplied by (ii) the Merger Consideration, except for certain RSUs granted following the date of the Merger Agreement which were converted at the Effective Time into restricted cash awards equal to the product of (a) the Merger Consideration multiplied by (b) the number of shares of Issuer common stock subject to such award and otherwise remain subject to their terms, including vesting and acceleration terms.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 02, 2019 Filed Jul 3, 2019 20:06 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 7,450 | $44.17 | $329,066.50 |
DisclosureSEC source: 0001225208-19-010036 · doc4.xml · nonDerivative · entry 11 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,434 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2019. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 20:06 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 7,272 | $44.04 | $320,258.88 |
DisclosureSEC source: 0001225208-19-010036 · doc4.xml · nonDerivative · entry 10 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,884 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2019. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 20:06 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 6,180 | $44.16 | $272,908.80 |
DisclosureSEC source: 0001225208-19-010036 · doc4.xml · nonDerivative · entry 9 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 460,156 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2019. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 20:06 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 4,864 | $44.08 | $214,405.12 |
DisclosureSEC source: 0001225208-19-010036 · doc4.xml · nonDerivative · entry 8 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 466,336 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2019. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 20:06 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 4,824 | $44.18 | $213,124.32 |
DisclosureSEC source: 0001225208-19-010036 · doc4.xml · nonDerivative · entry 7 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 471,200 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2019. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 20:06 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 3,425 | $44.14 | $151,179.50 |
DisclosureSEC source: 0001225208-19-010036 · doc4.xml · nonDerivative · entry 6 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476,024 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2019. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 20:06 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 3,403 | $44.02 | $149,800.06 |
DisclosureSEC source: 0001225208-19-010036 · doc4.xml · nonDerivative · entry 5 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 479,449 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2019. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 20:06 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 3,008 | $44.12 | $132,712.96 |
DisclosureSEC source: 0001225208-19-010036 · doc4.xml · nonDerivative · entry 4 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,852 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2019. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 20:06 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 2,787 | $44.03 | $122,711.61 |
DisclosureSEC source: 0001225208-19-010036 · doc4.xml · nonDerivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,860 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2019. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 20:06 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 1,000 | $44.19 | $44,190.00 |
DisclosureSEC source: 0001225208-19-010036 · doc4.xml · nonDerivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,647 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2019. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 20:06 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 929 | $44.13 | $40,996.77 |
DisclosureSEC source: 0001225208-19-010036 · doc4.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489,647 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2019. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 152,114 | $0.00 Strike: $43.35 | $0.00 |
DisclosureSEC source: 0001225208-19-004208 · doc4.xml · derivative · entry 8 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,114 Underlying: Common Stock · 152,114 shares Expires 2026-02-28 F8 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F8 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 180,503 | $0.00 Strike: $43.35 | $0.00 |
DisclosureSEC source: 0001225208-19-004208 · doc4.xml · derivative · entry 7 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,503 Underlying: Common Stock · 180,503 shares Expires 2024-02-28 F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 182,247 | $0.00 Strike: $32.23 | $0.00 |
DisclosureSEC source: 0001225208-19-004208 · doc4.xml · derivative · entry 6 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 182,247 shares Expires 2019-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 112,552 | $42.31 | $4,762,075.12 |
DisclosureSEC source: 0001225208-19-004208 · doc4.xml · nonDerivative · entry 5 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,576 F5 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F6 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 47,101 | $42.93 | $2,022,045.93 |
DisclosureSEC source: 0001225208-19-004208 · doc4.xml · nonDerivative · entry 4 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,128 F4 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 34,131 | $42.93 | $1,465,243.83 |
DisclosureSEC source: 0001225208-19-004208 · doc4.xml · nonDerivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650,229 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 96,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-004208 · doc4.xml · nonDerivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 684,360 F2 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 182,247 | $32.23 | $5,873,820.81 |
DisclosureSEC source: 0001225208-19-004208 · doc4.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 588,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:45 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 185,185 | $0.00 Strike: $21.03 | $0.00 |
DisclosureSEC source: 0001225208-19-003782 · doc4.xml · derivative · entry 4 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 185,185 shares Expires 2019-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:45 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 58,983 | $42.96 | $2,533,909.68 |
DisclosureSEC source: 0001225208-19-003782 · doc4.xml · nonDerivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 405,930 F4 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F5 · price: Price is the closing price of Pfizer common stock on February 22, 2019 Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:45 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 57,663 | $41.91 | $2,416,656.33 |
DisclosureSEC source: 0001225208-19-003782 · doc4.xml · nonDerivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,913 F2 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F3 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:45 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 185,185 | $21.03 | $3,894,440.55 |
DisclosureSEC source: 0001225208-19-003782 · doc4.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 522,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:12 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 4,150.3887 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-19-000101 · wf-form4_155078715349451.xml · derivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,058.3653 Underlying: Common Stock · 4,150.3887 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,150.3887 RSUs vested on February 19, 2019; 3,683.0826 RSUs will vest on February 14, 2020; 2,747.2827 RSUs will vest on February 13, 2021; and 2,628.0000 RSUs will vest on February 12, 2022. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,150.3887 RSUs vested on February 19, 2019; 3,683.0826 RSUs will vest on February 14, 2020; 2,747.2827 RSUs will vest on February 13, 2021; and 2,628.0000 RSUs will vest on February 12, 2022. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,150.3887 RSUs vested on February 19, 2019; 3,683.0826 RSUs will vest on February 14, 2020; 2,747.2827 RSUs will vest on February 13, 2021; and 2,628.0000 RSUs will vest on February 12, 2022. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:12 UTC | Zoetis Inc. ZTS · Entity 679 | OtherCommon Stock | 1,324 | $94.91 | $125,660.84 |
DisclosureSEC source: 0001555280-19-000101 · wf-form4_155078715349451.xml · nonDerivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,394 F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:12 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 4,150 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-19-000101 · wf-form4_155078715349451.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,718 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 23:47 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 2,628 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000043 · wf-form4_155018802915634.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,208.754 Underlying: Common Stock · 2,628 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 4,150.3887 RSUs will vest on February 19, 2019; 3,683.0826 RSUs will vest on February 14, 2020; 2,747.2827 RSUs will vest on February 13, 2021; and 2,628.0000 RSUs will vest on February 12, 2022. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 21:17 UTC | PFIZER INC PFE · Entity 2863 | OtherPhantom Stock Units SSP · Derivative | 42,690 | $42.44 | $1,811,763.60 |
DisclosureSEC source: 0001225208-19-001863 · doc4.xml · derivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,690 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · shares: This transaction constitutes an intra-plan transfer involving the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan. F4 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F4 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 21:17 UTC | PFIZER INC PFE · Entity 2863 | OtherCommon Stock | 5,182 | $42.44 | $219,924.08 |
DisclosureSEC source: 0001225208-19-001863 · doc4.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Rule 16b-3 Plan Disclosed balance after: 0 F1 · shares: This transaction constitutes an intra-plan transfer involving the Pfizer stock fund under the Company's Qualified Savings Plan. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 19:16 UTC | HUMANA INC HUM · Entity 1429 | GrantStock Unit · Derivative | 588 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-19-000010 · edgar.xml · derivative · entry 7 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 588 Underlying: Humana Common · 588 shares Expires not disclosed F5 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2019. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2019. F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2019. F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2019. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 19:33 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 150,484 | $40.00 | $6,019,360.00 |
DisclosureSEC source: 0001225208-18-012253 · doc4.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,391 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2017. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 209,251 | $0.00 Strike: $27.37 | $0.00 |
DisclosureSEC source: 0001225208-18-005096 · doc4.xml · derivative · entry 5 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 209,251 shares Expires 2018-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 127,015 | $35.70 | $4,534,435.50 |
DisclosureSEC source: 0001225208-18-005096 · doc4.xml · nonDerivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,875 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 40,271 | $36.31 | $1,462,240.01 |
DisclosureSEC source: 0001225208-18-005096 · doc4.xml · nonDerivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 614,890 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 209,251 | $27.37 | $5,727,199.87 |
DisclosureSEC source: 0001225208-18-005096 · doc4.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:21 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 3,771.06 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-18-000118 · wf-form4_151994287505808.xml · derivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,514.1921 Underlying: Common Stock · 3,771.06 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,771.0600 RSUs vested on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,771.0600 RSUs vested on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,771.0600 RSUs vested on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:21 UTC | Zoetis Inc. ZTS · Entity 679 | OtherCommon Stock | 1,203 | $81.67 | $98,249.01 |
DisclosureSEC source: 0001555280-18-000118 · wf-form4_151994287505808.xml · nonDerivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,568 F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:21 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 3,771 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-18-000118 · wf-form4_151994287505808.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 23:05 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 42,157 | $37.09 | $1,563,603.13 |
DisclosureSEC source: 0001225208-18-004660 · doc4.xml · nonDerivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,910 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 23:05 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 86,086 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-004660 · doc4.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,067 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:30 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 174,081 | $0.00 Strike: $18.90 | $0.00 |
DisclosureSEC source: 0001225208-18-004456 · doc4.xml · derivative · entry 5 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 174,081 shares Expires 2018-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:30 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 55,544 | $35.98 | $1,998,473.12 |
DisclosureSEC source: 0001225208-18-004456 · doc4.xml · nonDerivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,981 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:30 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 53,945 | $36.26 | $1,956,045.70 |
DisclosureSEC source: 0001225208-18-004456 · doc4.xml · nonDerivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 457,525 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 23, 2018 Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:30 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 174,081 | $18.90 | $3,290,130.90 |
DisclosureSEC source: 0001225208-18-004456 · doc4.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 20:47 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 120,792 | $0.00 Strike: $35.74 | $0.00 |
DisclosureSEC source: 0001225208-18-003965 · doc4.xml · derivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,792 Underlying: Common Stock · 120,792 shares Expires 2025-02-22 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 20:47 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 144,485 | $0.00 Strike: $35.74 | $0.00 |
DisclosureSEC source: 0001225208-18-003965 · doc4.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,485 Underlying: Common Stock · 144,485 shares Expires 2023-02-22 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 22:05 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 2,730 | $73.24 | $199,945.20 |
DisclosureSEC source: 0001555280-18-000066 · wf-form4_151873232301805.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,285.2521 Underlying: Common Stock · 2,730 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 3,771.0600 RSUs will vest on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 22:37 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 94,409 | $34.00 | $3,209,906.00 |
DisclosureSEC source: 0001225208-17-014482 · doc4.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,389 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2017. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 19,046 | $34.28 | $652,896.88 |
DisclosureSEC source: 0001225208-17-005101 · doc4.xml · nonDerivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431,798 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 18,838 | $34.28 | $645,766.64 |
DisclosureSEC source: 0001225208-17-005101 · doc4.xml · nonDerivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,844 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.